Related Experiment Video
Updated: Mar 15, 2026

Generating Whole Bacterial Genomes from Clinical Samples using a Target Enrichment Workflow
Published on: August 15, 2025
Background review for the 2016 European guideline on Mycoplasma genitalium infections
J S Jensen1, M Cusini2, M Gomberg3
1Microbiology and Infection Control, Statens Serum Institut, Copenhagen, Denmark. jsj@ssi.dk.
Abstract:
Mycoplasma genitalium is a cause of 10-35% of non-chlamydial non-gonococcal urethritis in men and in women, and is associated with cervicitis and pelvic inflammatory disease (PID). Transmission of M. genitalium occurs through direct mucosal contact. In women, symptoms include vaginal discharge, dysuria or symptoms of PID - abdominal pain and dyspareunia. In men, urethritis, dysuria and discharge predominates. Asymptomatic infections are frequent. In this review, we present the evidence base for the recommendations in the 2016 European guideline on M. genitalium infections and describe indications for testing, recommended diagnostic methods, treatment and patient management. The guideline was prepared on behalf of the European branch of The International Union against Sexually Transmitted Infections; the European Academy of Dermatology and Venereology; the European Dermatology Forum; the European Society of Clinical Microbiology and Infectious Diseases; the Union of European Medical Specialists. The European Centre for Disease Prevention and Control and the European Office of the World Health Organisation also contributed to their development.
Insights
Mycoplasma genitalium causes a significant portion of non-gonococcal urethritis in men and women, and is linked to pelvic inflammatory disease. This review details the 2016 European guideline for managing M. genitalium infections.
Area of Science:
- Sexually Transmitted Infections
- Microbiology
- Public Health
Background:
- Mycoplasma genitalium is a common cause of urethritis in men and cervicitis/pelvic inflammatory disease (PID) in women.
- Transmission occurs via direct mucosal contact, with frequent asymptomatic infections.
- Symptoms vary, including discharge, dysuria, abdominal pain, and dyspareunia.
Purpose of the Study:
- To present the evidence supporting the 2016 European guideline for Mycoplasma genitalium infections.
- To outline recommendations for diagnosis, treatment, and patient management.
- To consolidate expert consensus from multiple European societies.
Main Methods:
- Review of evidence base for the 2016 European guideline.
- Synthesis of recommendations from contributing European organizations.
- Inclusion of input from public health bodies like ECDC and WHO.
Main Results:
- The guideline addresses indications for testing, diagnostic methods, and treatment strategies.
- It provides a framework for managing M. genitalium infections in clinical practice.
- Evidence supports specific diagnostic and therapeutic approaches.
Conclusions:
- The 2016 European guideline offers comprehensive recommendations for Mycoplasma genitalium.
- Adherence to the guideline is crucial for effective patient management and control.
- The guideline reflects a collaborative effort by leading European medical societies.
Related Concept Videos
Sexually Transmitted Infections
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Acute Pyelonephritis II: Diagnostic Studies and Management
Urinary Tract Infection I: Introduction
Bacterial Phylum Tenericutes
Urinary Tract Infection II: Pathophysiology

